Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation

Monitoring of Epstein–Barr virus load in patients after allogeneic hematopoietic stem cell transplantation

(2012) P. Volfova et al.   INFECTION

T-cell therapy in the treatment of post-transplant lymphoproliferative disease

(2012) Catherine M. Bollard et al.   Nature Reviews Clinical Oncology

Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation

(2011) Z Peric et al.   LEUKEMIA

Epstein-Barr virus DNA load in peripheral blood mononuclear cells and whole blood from pediatric transplant recipients

(2011) B. Kasztelewicz et al.   Transplant Infectious Disease

Rituximab Treatment for Epstein-Barr Virus DNAemia after Alternative-Donor Hematopoietic Stem Cell Transplantation

(2010) Stefania Coppoletta et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Molecular monitoring of viral infections after hematopoietic stem cell transplantation

(2010) Per Ljungman   INTERNATIONAL JOURNAL OF HEMATOLOGY

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

(2009) O. Landgren et al.   BLOOD

How we treat cytomegalovirus in hematopoietic cell transplant recipients

(2009) M. Boeckh et al.   BLOOD

How I treat EBV lymphoproliferation

(2009) H. E. Heslop   BLOOD

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

(2009) J. Styczynski et al.   Transplant Infectious Disease

Preemptive Management of Epstein-Barr Virus Reactivation After Hematopoietic Stem-Cell Transplantation

(2009) Imran Ahmad et al.   TRANSPLANTATION

Kinetics of Epstein-Barr Virus DNA Load in Different Blood Compartments of Pediatric Recipients of T-Cell-Depleted HLA-Haploidentical Stem Cell Transplantation

(2008) F. Baldanti et al.   JOURNAL OF CLINICAL MICROBIOLOGY